Efficacy and Safety of NKT Cell-stimulatory Glycolipid OCH-NCNP1 for Patients with Relapsing Multiple Sclerosis: Protocol for a Randomized, Placebo-Controlled Clinical Trial (Preprint)
JMIR research protocols